SHP Wealth Management’s Dr. Reddy's Laboratories RDY Stock Holding History

SHP Wealth Management’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.98K	Buy	+504	New	+$7.02K	﹤0.01%	989

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

SHP Wealth Management's RDY Position: Q1 2026 in Review

SHP Wealth Management opened a new position in Dr. Reddy's Laboratories (RDY) in Q1 2026: 504 shares worth $6.98K. The stake represents ﹤0.01% of the portfolio and ranks #989 among its holdings.

248 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

SHP Wealth Management held 504 shares of Dr. Reddy's Laboratories worth $6.98K as of Q1 2026.
Dr. Reddy's Laboratories was a new SHP Wealth Management position in Q1 2026.
Dr. Reddy's Laboratories made up ﹤0.01% of SHP Wealth Management's portfolio in Q1 2026, its #989 holding.
248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on SHP Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.